Teligent
TLGT
#10339
Rank
A$23.25 M
Marketcap
A$0.25
Share price
-13.85%
Change (1 day)
1,444.06%
Change (1 year)
Teligent is an American pharmaceutical company that develops and markets injectable and topical prescription medicines.

Earnings for Teligent (TLGT)

Earnings in 2021 (TTM): -A$58.52 Million

According to Teligent's latest financial reports the company's current earnings are A$46.29 Million. In 2020 the company made an earning of -A$55.47 Million a decrease over its 2019 earnings that were of -A$11.59 Million.

Earnings history for Teligent from 2001 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-A$58.52 Million5.51%
2020-A$55.47 Million378.89%
2019-A$11.59 Million-46.87%
2018-A$21.8 Million10.47%
2017-A$19.74 Million-637.49%
2016A$3.67 M-179.64%
2015-A$4.61 Million-181.72%
2014A$5.64 M-4806.02%
2013-A$0.12 Million-97.35%
2012-A$4.53 Million6.23%
2011-A$4.27 Million-18.59%
2010-A$5.24 Million-11.37%
2009-A$5.91 Million98.4%
2008-A$2.98 Million156.15%
2007-A$1.17 Million-59.36%
2006-A$2.87 Million17.92%
2005-A$2.43 Million37.7%
2004-A$1.77 Million25.51%
2003-A$1.41 Million-289.84%
2002A$0.73 M-1605.88%
2001-A$0.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.24 Billion 262.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$26.22 Million-58.71%๐Ÿ‡บ๐Ÿ‡ธ USA